Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2013

01.10.2013 | Breast Oncology

Geographic and Temporal Trends in the Management of Occult Primary Breast Cancer: A Systematic Review and Meta-Analysis

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Management of occult primary breast cancer (OPBC), including the role of magnetic resonance imaging (MRI), is controversial. We conducted a pooled analysis of OPBC patients and a meta-analysis of MRI accuracy in OPBC in order to elucidate current practices.

Methods

A literature search yielded 201 studies. Patient-level data for clinically/mammographically OPBC from studies published after 1993 and from our institution were pooled; logistic regression examined associations between patient/study data and outcomes, including treatments and recurrence. We report adjusted odds ratios (OR) and 95 % confidence intervals (95 % CI) significant at 2-tailed p < 0.05. Meta-analysis included data for patients who received MRIs for workup of clinically/mammographically OPBC. We report pooled sensitivity and specificity with 95 % CIs.

Results

The pooled analysis included 92 patients (15 studies [n = 85] plus our institution [n = 7]). Patients from Asia were more likely to receive breast surgery (OR = 5.98, 95 % CI = 2.02–17.65) but not chemotherapy (OR = 0.32, 95 % CI = 0.13–0.82); patients from the United States were more likely to receive chemotherapy (OR = 13.08, 95 % CI = 2.64–64.78). Patients from studies published after 2003 were more likely to receive radiotherapy (OR = 3.86, 95 % CI = 1.41–10.55). Chemotherapy recipients were more likely to have distant recurrence (OR = 9.77, 95 % CI = 1.10–87.21). More patients with positive MRIs received chemotherapy than patients with negative MRIs (10 of 12 [83.3 %] vs 5 of 13 [38.5 %]; p = 0.0414). In the MRI-accuracy meta-analysis (10 studies, n = 262), pooled sensitivity and specificity were 96 % (95 % CI = 91–98 %) and 63 % (95 % CI = 42–81 %), respectively.

Conclusions

OPBC management varied geographically and over time. We recommend establishing an international OPBC patient registry to facilitate longitudinal study and develop global treatment standards.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Halsted WS. The result of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1–19.PubMedCrossRef Halsted WS. The result of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1–19.PubMedCrossRef
2.
Zurück zum Zitat Patel J, Nemoto T, Rosner D. Axillary lymph node metastasis from an occult breast cancer. Cancer. 1981;47:2923–7.PubMedCrossRef Patel J, Nemoto T, Rosner D. Axillary lymph node metastasis from an occult breast cancer. Cancer. 1981;47:2923–7.PubMedCrossRef
3.
Zurück zum Zitat Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP, Petrek JA. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg. 1990;125:210–14.PubMedCrossRef Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP, Petrek JA. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg. 1990;125:210–14.PubMedCrossRef
4.
Zurück zum Zitat Rosen PP, Kimmel M. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol. 1990;21:518–23.PubMedCrossRef Rosen PP, Kimmel M. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol. 1990;21:518–23.PubMedCrossRef
5.
Zurück zum Zitat Olson JA, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411–5.PubMedCrossRef Olson JA, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411–5.PubMedCrossRef
6.
Zurück zum Zitat Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001;8:425–31.PubMedCrossRef Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001;8:425–31.PubMedCrossRef
7.
Zurück zum Zitat Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, et al. Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat. 2011;129:867–75.PubMedCrossRef Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, et al. Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat. 2011;129:867–75.PubMedCrossRef
8.
Zurück zum Zitat Davis PL, Julian TB, Staiger M, Harris KB, Borochovitz D, Klementaviciene J, et al. Magnetic resonance imaging detection and wire localization of an ‘occult’ breast cancer. Breast Cancer Res Treat. 1994;32:327–30.PubMedCrossRef Davis PL, Julian TB, Staiger M, Harris KB, Borochovitz D, Klementaviciene J, et al. Magnetic resonance imaging detection and wire localization of an ‘occult’ breast cancer. Breast Cancer Res Treat. 1994;32:327–30.PubMedCrossRef
10.
Zurück zum Zitat de Bresser J, de Vos B, van der Ent F, Hulsewe K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol. 2010;36:114–9.PubMedCrossRef de Bresser J, de Vos B, van der Ent F, Hulsewe K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol. 2010;36:114–9.PubMedCrossRef
11.
Zurück zum Zitat Pentheroudakis G, Lazaridis G, Pavlidis N. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat. 2010;119:1–11.PubMedCrossRef Pentheroudakis G, Lazaridis G, Pavlidis N. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat. 2010;119:1–11.PubMedCrossRef
12.
Zurück zum Zitat Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–93.PubMedCrossRef Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–93.PubMedCrossRef
13.
Zurück zum Zitat DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008;15:408–16.PubMedCrossRef DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008;15:408–16.PubMedCrossRef
14.
Zurück zum Zitat Abe H, Naitoh H, Umeda T, Shiomi H, Tani T, Kodama M, et al. Occult breast cancer presenting axillary nodal metastasis: a case report. Jpn J Clin Oncol. 2000;30:185–7.PubMedCrossRef Abe H, Naitoh H, Umeda T, Shiomi H, Tani T, Kodama M, et al. Occult breast cancer presenting axillary nodal metastasis: a case report. Jpn J Clin Oncol. 2000;30:185–7.PubMedCrossRef
15.
Zurück zum Zitat Abe H, Shimizu T, Cho H, Kubota Y, Umeda T, Kurumi Y, et al. Occult breast cancer with EDTA-dependent pseudothrombocytopenia—a case report. Jpn J Cancer Chemother. 2010;37(5):915–918. Abe H, Shimizu T, Cho H, Kubota Y, Umeda T, Kurumi Y, et al. Occult breast cancer with EDTA-dependent pseudothrombocytopenia—a case report. Jpn J Cancer Chemother. 2010;37(5):915–918.
16.
Zurück zum Zitat Agarwal G, Mishra SK, Dutta NR, Jain M. Occult squamous cell carcinoma of the axillary tail of breast presenting as isolated axillary lymph node mass. Eur J Surg. 2000;166:177–9.PubMedCrossRef Agarwal G, Mishra SK, Dutta NR, Jain M. Occult squamous cell carcinoma of the axillary tail of breast presenting as isolated axillary lymph node mass. Eur J Surg. 2000;166:177–9.PubMedCrossRef
17.
Zurück zum Zitat Capobianco G, Spaliviero B, Dessole S, Rocca PC, Cherchi PL, Ambrosini G, et al. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis. Breast J. 2007;13:305–7.PubMedCrossRef Capobianco G, Spaliviero B, Dessole S, Rocca PC, Cherchi PL, Ambrosini G, et al. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis. Breast J. 2007;13:305–7.PubMedCrossRef
18.
Zurück zum Zitat Ko EY, Han BK, Shin JH, Kang SS. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol. 2007;8:382–9.PubMedCrossRef Ko EY, Han BK, Shin JH, Kang SS. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol. 2007;8:382–9.PubMedCrossRef
19.
Zurück zum Zitat Lanitis S, Behranwala KA, Al-Mufti R, Hadjiminas D. Axillary metastatic disease as presentation of occult or contralateral breast cancer. Breast. 2009;18:225–7.PubMedCrossRef Lanitis S, Behranwala KA, Al-Mufti R, Hadjiminas D. Axillary metastatic disease as presentation of occult or contralateral breast cancer. Breast. 2009;18:225–7.PubMedCrossRef
20.
Zurück zum Zitat Lloyd MS, Nash AG. ‘Occult’ breast cancer. Ann R Coll Surg Engl. 2001;83:420–4.PubMed Lloyd MS, Nash AG. ‘Occult’ breast cancer. Ann R Coll Surg Engl. 2001;83:420–4.PubMed
21.
Zurück zum Zitat Matsuoka K, Ohsumi S, Takashima S, Saeki T, Aogi K, Mandai K. Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients. Breast Cancer. 2003;10:330–4.PubMedCrossRef Matsuoka K, Ohsumi S, Takashima S, Saeki T, Aogi K, Mandai K. Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients. Breast Cancer. 2003;10:330–4.PubMedCrossRef
22.
Zurück zum Zitat Medina-Franco H, Urist MM. Occult breast carcinoma presenting with axillary lymph node metastases. Rev Invest Clin. 2002;54:204–8.PubMed Medina-Franco H, Urist MM. Occult breast carcinoma presenting with axillary lymph node metastases. Rev Invest Clin. 2002;54:204–8.PubMed
23.
Zurück zum Zitat Misra AK, Mishra A, Agrawal G, Agarwal A, Mishra SK. Occult breast carcinoma: a report of four cases and review of literature. Indian J Cancer. 2001;38:49–54.PubMed Misra AK, Mishra A, Agrawal G, Agarwal A, Mishra SK. Occult breast carcinoma: a report of four cases and review of literature. Indian J Cancer. 2001;38:49–54.PubMed
24.
Zurück zum Zitat Piekarski J, Pluta P, Nejc D, Jeziorski A. Mastectomy is an over-treatment in patients with occult breast cancer. Nowotwory. 2003;53:630–4. Piekarski J, Pluta P, Nejc D, Jeziorski A. Mastectomy is an over-treatment in patients with occult breast cancer. Nowotwory. 2003;53:630–4.
25.
Zurück zum Zitat Steunebrink M, Schnater JM, Storm RK, van Ingen G, Vegt PA, Plaisier PW. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature. Breast. 2005;14:165–8.PubMedCrossRef Steunebrink M, Schnater JM, Storm RK, van Ingen G, Vegt PA, Plaisier PW. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature. Breast. 2005;14:165–8.PubMedCrossRef
26.
Zurück zum Zitat Tamiolakis D, Antoniou C. Axillary nodal metastasis of occult breast primary cancer. Chirurgia (Bucur). 2008;103:467–71.PubMed Tamiolakis D, Antoniou C. Axillary nodal metastasis of occult breast primary cancer. Chirurgia (Bucur). 2008;103:467–71.PubMed
27.
Zurück zum Zitat Teodossiu G, Andrikou K, Lazzaro R, Filiotis N, Triggiani E. Occult breast cancer presenting with axillary nodal metastasis: a case report. Eur J Oncol. 2009;14:109–13. Teodossiu G, Andrikou K, Lazzaro R, Filiotis N, Triggiani E. Occult breast cancer presenting with axillary nodal metastasis: a case report. Eur J Oncol. 2009;14:109–13.
28.
Zurück zum Zitat Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 2006;71:456–9.PubMedCrossRef Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 2006;71:456–9.PubMedCrossRef
29.
Zurück zum Zitat Fayanju OM, Jeffe DB, Margenthaler JA. Occult primary breast cancer at a comprehensive cancer center. J Surg Res. 2013 (in press). Fayanju OM, Jeffe DB, Margenthaler JA. Occult primary breast cancer at a comprehensive cancer center. J Surg Res. 2013 (in press).
30.
Zurück zum Zitat Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005;12:1045–53.PubMedCrossRef Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005;12:1045–53.PubMedCrossRef
31.
Zurück zum Zitat Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg. 1999;178:496–500.PubMedCrossRef Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg. 1999;178:496–500.PubMedCrossRef
32.
Zurück zum Zitat Lu H, Xu YL, Zhang SP, Lang RG, Zee CS, Liu PF, et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: Evaluation on feasibility and correlation with histopathological findings. Chin Med J. 2011;124:1790–5.PubMed Lu H, Xu YL, Zhang SP, Lang RG, Zee CS, Liu PF, et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: Evaluation on feasibility and correlation with histopathological findings. Chin Med J. 2011;124:1790–5.PubMed
33.
Zurück zum Zitat McMahon K, Medoro L, Kennedy D. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin. Australas Radiol. 2005;49:382–9.PubMedCrossRef McMahon K, Medoro L, Kennedy D. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin. Australas Radiol. 2005;49:382–9.PubMedCrossRef
34.
Zurück zum Zitat Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997;205:437–40.PubMed Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997;205:437–40.PubMed
35.
Zurück zum Zitat Obdeijn IMA, Brouwers-Kuyper EMJ, Tilanus-Linthorst MMA, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol. 2000;174:1079–84.PubMedCrossRef Obdeijn IMA, Brouwers-Kuyper EMJ, Tilanus-Linthorst MMA, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol. 2000;174:1079–84.PubMedCrossRef
36.
Zurück zum Zitat Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999;212:543–9.PubMed Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999;212:543–9.PubMed
37.
Zurück zum Zitat Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E. MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol. 1999;9:470–3.PubMedCrossRef Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E. MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol. 1999;9:470–3.PubMedCrossRef
38.
Zurück zum Zitat Tilanus-Linthorst MMA, Obdeijn AIM, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat. 1997;44:179–82.PubMedCrossRef Tilanus-Linthorst MMA, Obdeijn AIM, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat. 1997;44:179–82.PubMedCrossRef
39.
Zurück zum Zitat Barton SR, Smith IE, Kirby AM, Ashley S, Walsh G, Parton M. The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy. Eur J Cancer. 2011;47:2099–106.PubMedCrossRef Barton SR, Smith IE, Kirby AM, Ashley S, Walsh G, Parton M. The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy. Eur J Cancer. 2011;47:2099–106.PubMedCrossRef
40.
Zurück zum Zitat Brill KL, Brenin DR. Occult breast cancer and axillary mass. Curr Treat Options Oncol. 2001;2:149–55.PubMedCrossRef Brill KL, Brenin DR. Occult breast cancer and axillary mass. Curr Treat Options Oncol. 2001;2:149–55.PubMedCrossRef
41.
Zurück zum Zitat Carr JA. Treating occult breast malignancy presenting as axillary node metastases. J Am Coll Surg. 2007;204:517–8.PubMedCrossRef Carr JA. Treating occult breast malignancy presenting as axillary node metastases. J Am Coll Surg. 2007;204:517–8.PubMedCrossRef
42.
Zurück zum Zitat Foroudi F, Tiver KW. Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys. 2000;47:143–7.PubMedCrossRef Foroudi F, Tiver KW. Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys. 2000;47:143–7.PubMedCrossRef
43.
Zurück zum Zitat Masinghe SP, Faluyi OO, Kerr GR, Kunkler IH. Breast radiotherapy for occult breast cancer with axillary nodal metastases—does it reduce the local recurrence rate and increase overall survival? Clin Oncol. 2011;23:95–100.CrossRef Masinghe SP, Faluyi OO, Kerr GR, Kunkler IH. Breast radiotherapy for occult breast cancer with axillary nodal metastases—does it reduce the local recurrence rate and increase overall survival? Clin Oncol. 2011;23:95–100.CrossRef
44.
45.
Zurück zum Zitat Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.PubMedCrossRef Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.PubMedCrossRef
46.
Zurück zum Zitat Merson M, Andreola S, Galimberti V, Bufalino R, Marchini S, Veronesi U. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 1992;70:504–8.PubMedCrossRef Merson M, Andreola S, Galimberti V, Bufalino R, Marchini S, Veronesi U. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 1992;70:504–8.PubMedCrossRef
47.
Zurück zum Zitat van Ooijen B, Bontenbal M, Henzen-Logmans SC, Koper PC. Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg. 1993;80:1299–300.PubMedCrossRef van Ooijen B, Bontenbal M, Henzen-Logmans SC, Koper PC. Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg. 1993;80:1299–300.PubMedCrossRef
48.
Zurück zum Zitat Vezzoni P, Balestrazzi A, Bignami P. Axillary lymph node metastases from occult carcinoma of the breast. Tumori. 1979;65:87–91.PubMed Vezzoni P, Balestrazzi A, Bignami P. Axillary lymph node metastases from occult carcinoma of the breast. Tumori. 1979;65:87–91.PubMed
49.
Zurück zum Zitat Yang T-IJ, Yang Q, Haffty BG, Moran MS. Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys. 2010;76:79–84.PubMedCrossRef Yang T-IJ, Yang Q, Haffty BG, Moran MS. Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys. 2010;76:79–84.PubMedCrossRef
50.
Zurück zum Zitat Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, et al. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013;216:966–75.PubMedCrossRef Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, et al. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013;216:966–75.PubMedCrossRef
51.
Zurück zum Zitat Gelber RP, McCarthy EP, Davis JW, Seto TB. Ethnic disparities in breast cancer management among Asian Americans and Pacific Islanders. Ann Surg Oncol. 2006;13:977–84.PubMedCrossRef Gelber RP, McCarthy EP, Davis JW, Seto TB. Ethnic disparities in breast cancer management among Asian Americans and Pacific Islanders. Ann Surg Oncol. 2006;13:977–84.PubMedCrossRef
52.
Zurück zum Zitat Lim SE, Back M, Quek E, Iau P, Putti T, Wong JEL. Clinical observations from a breast cancer registry in Asian women. World J Surg. 2007;31:1387–92.PubMedCrossRef Lim SE, Back M, Quek E, Iau P, Putti T, Wong JEL. Clinical observations from a breast cancer registry in Asian women. World J Surg. 2007;31:1387–92.PubMedCrossRef
53.
Zurück zum Zitat Pham JT, Allen LJ, Gomez SL. Why do Asian-American women have lower rates of breast conserving surgery: results of a survey regarding physician perceptions. BMC Public Health. 2009;9:246.PubMedCrossRef Pham JT, Allen LJ, Gomez SL. Why do Asian-American women have lower rates of breast conserving surgery: results of a survey regarding physician perceptions. BMC Public Health. 2009;9:246.PubMedCrossRef
54.
Zurück zum Zitat Padhani AR, Ah-See MLW, Makris A. MRI in the detection and management of breast cancer. Expert Rev Anticancer Ther. 2005;5:239–52.PubMedCrossRef Padhani AR, Ah-See MLW, Makris A. MRI in the detection and management of breast cancer. Expert Rev Anticancer Ther. 2005;5:239–52.PubMedCrossRef
55.
Zurück zum Zitat Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin North Am. 2010;19:475–92.CrossRef Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin North Am. 2010;19:475–92.CrossRef
56.
Zurück zum Zitat Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;378:1804–11.PubMedCrossRef Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;378:1804–11.PubMedCrossRef
57.
Zurück zum Zitat Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev. 2009;35:570–3.PubMedCrossRef Golfinopoulos V, Pentheroudakis G, Salanti G, Nearchou AD, Ioannidis JP, Pavlidis N. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev. 2009;35:570–3.PubMedCrossRef
58.
Zurück zum Zitat Morrow M. MRI for breast cancer screening and staging. Menopause. 2011;18:1337.CrossRef Morrow M. MRI for breast cancer screening and staging. Menopause. 2011;18:1337.CrossRef
59.
Zurück zum Zitat Bloom S, Morrow M. A clinical oncologic perspective on breast magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:277–94.PubMedCrossRef Bloom S, Morrow M. A clinical oncologic perspective on breast magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:277–94.PubMedCrossRef
60.
Zurück zum Zitat Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703–11.PubMedCrossRef Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703–11.PubMedCrossRef
61.
Zurück zum Zitat Krämer A, Hübner G, Schneeweiss A, Folprecht G, Neben K. Carcinoma of unknown primary—an orphan disease? Breast Care. 2008;3:164–70.PubMed Krämer A, Hübner G, Schneeweiss A, Folprecht G, Neben K. Carcinoma of unknown primary—an orphan disease? Breast Care. 2008;3:164–70.PubMed
65.
Zurück zum Zitat El-Barhoun EN, Pitman AG. Impact of breast MR in non-screening Australian clinical practice: Audit data from a single-reader single-centre site. J Med Imaging Radiat Oncol. 2011;55:461–73.PubMedCrossRef El-Barhoun EN, Pitman AG. Impact of breast MR in non-screening Australian clinical practice: Audit data from a single-reader single-centre site. J Med Imaging Radiat Oncol. 2011;55:461–73.PubMedCrossRef
66.
Zurück zum Zitat Bartella L, Smith CS, Dershaw DD, Liberman L. Imaging breast cancer. Radiol Clin North Am. 2007;45:45–67.PubMedCrossRef Bartella L, Smith CS, Dershaw DD, Liberman L. Imaging breast cancer. Radiol Clin North Am. 2007;45:45–67.PubMedCrossRef
Metadaten
Titel
Geographic and Temporal Trends in the Management of Occult Primary Breast Cancer: A Systematic Review and Meta-Analysis
Publikationsdatum
01.10.2013
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3157-5

Weitere Artikel der Ausgabe 10/2013

Annals of Surgical Oncology 10/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.